Here are five things to know.
1. At least six clinical labs accused of overcharging Medicare remain involved in bankruptcy court. These include Houston-based CompanionDX Reference Lab, Charleston, S.C.-based Iverson Genetic Diagnostics, Louisville, Ky.-based PGXL Laboratories, Renton, Wash.-based Natural Molecular Testing Corp., and Richmond, Va.-based Health Diagnostic Laboratory.
2. The labs reportedly performed urine, genetic or heart disease tests that Medicare deems were overcharges because they weren’t considered “medically necessary.”
3. Medicare faces challenges in receiving repayment, as some physician-owned labs have tried to avoid paying, and several indebted testing firms “appear to have few assets to repay overcharges dating back years,” according to KHN, which cites court records.
4. Labs, however, have contested Medicare’s findings, according to the report.
5. Neither CMS nor the U.S. Department of Justice commented to KHN, the report states.
For more on this story, including information about the individual lab cases, read KHN‘s full report here.
More articles on healthcare finance:
Florida hospital alliances ask for $57M in funding to mitigate looming physician shortage
Partners HealthCare turns around worst financial loss to a profit in FY 2017
12 recent hospital, health system outlook and credit rating actions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.